Skip to content
Stop using now Drug recall · FDA · Published December 26, 2023

Haleon recalls Robitussin Honey CF Max Nighttime Adult due to microbial contamination

Haleon recalls Robitussin Honey CF Max Nighttime Adult bottles with microbial contamination risk. Affected lots expire June 2026. Consumers should stop using and contact Haleon for details.

🇺🇸 FDA recall #D-0317-2024DrugHaleon ›
Take action

Contact the company

Recalling firmHaleon US Holdings LLC184 Liberty Corner Rd · Warren, NJ 07059-6796
✎ GovInfoNow plain-language explainer

What happened, in plain English

Haleon is recalling Robitussin Honey CF Max Nighttime Adult bottles that may contain microbial contamination. This poses a risk of infection or illness if consumed. Affected bottles have specific lot numbers and expiration dates. Read more at govinfonow.com/recall/32909-haleon-recalls-robitussin-honey-cf-max-nighttime-adult-due-to.

Source Summary by GovInfoNow · govinfonow.com/recall/32909-haleon-recalls-robitussin-honey-cf-max-nighttime-adult-due-to · Updated September 23, 2026 · FDA enforcement record: FDA #D-0317-2024

Cite this page

“Haleon recalls Robitussin Honey CF Max Nighttime Adult due to microbial contamination.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32909-haleon-recalls-robitussin-honey-cf-max-nighttime-adult-due-to. Based on FDA recall #D-0317-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0317-2024%22&limit=1).

Why it’s dangerous

Microbial contamination means harmful bacteria or other microorganisms may be present in the product. If consumed, this could cause infection or illness. The product is non-sterile, so contamination is possible during manufacturing.

Who’s affected

Adults who purchased Robitussin Honey CF Max Nighttime Adult bottles with lot numbers T08740 or T08742, expiring June 30, 2026, are affected. Children and infants should not use this product.

How to tell if you have this one

Check the bottle label for lot numbers T08740 or T08742. The product expires June 30, 2026. This product is distributed by GSK Consumer Healthcare.

  • Brand
    Haleon
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Terminated
  • Distribution
    USA nationwide
Recall numberProduct, codes & lotsQuantity
D-0316-2024Robitussin Honey CF Max Non-Drowsy Adult (Acetaminophen 650mg, Dextromethorphan HBr 20 mg), a) 4 FL OZ (118mL) and b) 8 FL OZ (237 mL) bottles, Distributed by: GSK Consumer Healthcare, Warren, NJ 07059; a) Lot#: T10810, Exp 10/31/2025 b) Lot#: T08730, T08731, T08732, T08733, Exp 05/31/2025; T10808, Exp 09/30/2025a) 31,632 bottles; b) 336,528 bottles
D-0317-2024Robitussin Honey CF Max Nighttime Adult (Acetaminophen 650 mg, Diphenhydramine HCl 25mg), 8 FL OZ (237 mL) bottle, Distributed by: GSK Consumer Healthcare, Warren, NJ 07059; Lot#: T08740, T08742, Exp 06/30/202621,900 bottles
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled Robitussin Honey CF Max Nighttime Adult bottles with lot numbers T08740 or T08742.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.8 years after the firm started it.

1. Firm started the recall: Dec 26, 202312. Published in FDA’s Enforcement Report: Jan 31, 202423. FDA classified it Class I: Feb 7, 202434. FDA terminated the recall: Oct 5, 2026420232026
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Haleon recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0317-2024 (December 26, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0317-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA